Legacy Pharmaceuticals International is dedicated to customer-focused contract manufacturing of large and small volume products and the ownership and licensing of small volume but difficult to produce niche drugs. Products produced by Legacy meet the needs of patients in over 70 countries world-wide.

Formed in 2007, with the acquisition from Valeant Pharmaceuticals International of two world-class manufacturing sites and selected brands, Legacy is ideally positioned to capitalize upon the changing manufacturing trends in today's evolving pharmaceutical marketplace.

7 May, 2010
New packaging line FDA-certified
Basel, Switzerland -- Legacy Pharmaceuticals Switzerland is now ready for the US market. A new packaging area has been successfully approved by the American Food and Drug Administration (FDA). Customer orders will be manufactured from June onwards.


2008 Legacy Pharmaceuticals International          
Site Map